Help us: Donate
Follow us on:



Tyler Golato on Decentralized Development at EARD2020

Molecule might be a key player in bridging the valley of death.

Dr. Tyler GolatoDr. Tyler Golato

In this presentation given at Ending Age-Related Diseases 2020, Dr. Tyler Golato talked about his company, Molecule, highlighting the current problems with pharmaceutical development and offering a new, decentralized method of developing therapies. He discussed the well-known valley of death, the gap between the basic research of academia and the later-stage development of pharmaceutical companies. Dr. Golato advertises Molecule as a method of fostering collaboration between early developers and pharmaceutical companies in order to bridge this gap, particularly in the context of rejuvenation biotechnology.

Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension: YouTube Facebook Twitter Instagram Instagram Discord
Thank You!

No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.